Daniel P. O'Day - Sep 10, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Edward S. Son by Power of Attorney for Daniel P. O'Day
Stock symbol
GILD
Transactions as of
Sep 10, 2023
Transactions value $
-$255,816
Form type
4
Date filed
9/11/2023, 09:11 PM
Previous filing
Jun 12, 2023
Next filing
Dec 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +7.35K +1.94% 387K Sep 10, 2023 Direct F1
transaction GILD Common Stock Tax liability -$256K -3.37K -0.87% $76.00 384K Sep 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -7.35K -5.85% 118K Sep 10, 2023 Common Stock 7.35K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.